Stevanato Group S.p.A (STVN) Cash from Financing Activities (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Cash from Financing Activities of -$29.2 million for Q1 2026, up 22.37% year-over-year from -$23.8 million in Q1 2025, and down 245.6% on a QoQ basis from $20.0 million in Q4 2025.
Stevanato Group S.p.A (STVN) has 7 years of Cash from Financing Activities data on file, last reported at -$29.2 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 22.37% year-over-year to -$29.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.5 million (up 2223.28% YoY) and the FY2025 annual result came in at $25.7 million, down 86.86% from the prior year.
- Cash from Financing Activities eased to -$29.2 million in Q1 2026 per STVN's latest filing, from $20.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $159.6 million in Q1 2024 and bottomed at -$64.0 million in Q2 2024.
- The 5-year median for Cash from Financing Activities is $8.6 million (2023), against an average of $19.0 million.
- The widest annual swing landed in 2024, when Cash from Financing Activities jumped 1758.52%; it then slumped 123.53% in 2025.
- Tracing STVN's Cash from Financing Activities over 5 years: stood at -$19.0 million in 2022, then soared by 597.24% to $94.4 million in 2023, then slipped by 24.92% to $70.8 million in 2024, then plunged by 71.74% to $20.0 million in 2025, then plunged by 245.6% to -$29.2 million in 2026.
- Per Business Quant, the three latest STVN Cash from Financing Activities figures stand at -$29.2 million (Q1 2026), $20.0 million (Q4 2025), and $22.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -255.24 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -308.70 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -50.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | -147.90 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -48.13 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -11.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -230.34 Mn |
| 10 | Stevanato Group S.p.A | 5.73 Bn | 5.59 Bn | 88.04 Mn | -29.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.15 Mn |
| Mar 31, 2026 | -29.15 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | -37.55 Mn |
| Mar 31, 2025 | -37.55 Mn |
| Dec 31, 2024 | 70.85 Mn |
| Dec 31, 2024 | 70.85 Mn |
| Sep 30, 2024 | 32.29 Mn |
| Sep 30, 2024 | 32.29 Mn |
| Jun 30, 2024 | -63.97 Mn |
| Jun 30, 2024 | -63.97 Mn |
| Mar 31, 2024 | 159.59 Mn |
| Mar 31, 2024 | 159.59 Mn |
| Dec 31, 2023 | 94.36 Mn |
| Dec 31, 2023 | 94.36 Mn |
| Sep 30, 2023 | 110.71 Mn |
| Sep 30, 2023 | 110.71 Mn |
| Jun 30, 2023 | -42.79 Mn |
| Jun 30, 2023 | -42.79 Mn |
| Mar 31, 2023 | 8.59 Mn |
| Mar 31, 2023 | 8.59 Mn |
| Dec 31, 2022 | -18.98 Mn |
| Dec 31, 2022 | -18.98 Mn |
| Sep 30, 2022 | -9.98 Mn |
| Sep 30, 2022 | -9.98 Mn |
| Jun 30, 2022 | -20.38 Mn |
| Jun 30, 2022 | -20.38 Mn |
| Mar 31, 2022 | 3.48 Mn |
| Mar 31, 2022 | 3.48 Mn |
| Dec 31, 2021 | -59.94 Mn |
| Dec 31, 2021 | -59.94 Mn |
| Sep 30, 2021 | 397.54 Mn |
| Sep 30, 2021 | 397.54 Mn |
| Jun 30, 2021 | -12.04 Mn |
| Jun 30, 2021 | -12.04 Mn |
| Mar 31, 2021 | -23.88 Mn |
| Mar 31, 2021 | -23.88 Mn |
| Dec 31, 2020 | -31.36 Mn |
| Dec 31, 2020 | -31.36 Mn |
| Sep 30, 2020 | -24.18 Mn |
| Sep 30, 2020 | -24.18 Mn |
| Jun 30, 2020 | 19.17 Mn |
| Jun 30, 2020 | 19.17 Mn |